Blood Group Antibodies in Obstetrics: A continuing problem?

Area of Science:

• Obstetrics and Gynecology
• Immunology
• Transfusion Medicine

Background:

• Blood group antibodies can impact pregnancy outcomes.
• Hemolytic disease of the newborn (HDN) is a significant concern.

Purpose of the Study:

• To assess the frequency, nature, and effects of blood group antibodies on obstetrical outcomes.
• To identify the specific antibodies associated with adverse pregnancy events.

Main Methods:

• Retrospective survey conducted over 4 years.
• Analysis of patient data from a large community hospital.
• Identification and classification of 189 antibodies in 165 patients.

Main Results:

• Twenty clinically significant obstetrical outcomes were recorded.
• Three stillbirths were among the adverse outcomes.
• All significant cases of hemolytic disease of the newborn were attributed to Rh antibodies.

Conclusions:

• Blood group antibodies, particularly Rh antibodies, pose a risk to obstetrical outcomes.
• Monitoring and management of blood group antibodies are crucial in pregnancy.
• Rh antibodies are a key factor in severe hemolytic disease of the newborn.